These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 22348467)
1. Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation. Stravitz RT; Shiffman ML; Kimmel M; Puri P; Luketic VA; Sterling RK; Sanyal AJ; Cotterell AH; Posner MP; Fisher RA Liver Int; 2012 Aug; 32(7):1138-45. PubMed ID: 22348467 [TBL] [Abstract][Full Text] [Related]
2. Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective. Wesdorp DJ; Knoester M; Braat AE; Coenraad MJ; Vossen AC; Claas EC; van Hoek B J Clin Virol; 2013 Sep; 58(1):67-73. PubMed ID: 23880162 [TBL] [Abstract][Full Text] [Related]
3. Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation. McGonigal KH; Bajjoka IE; Abouljoud MS Pharmacotherapy; 2013 Sep; 33(9):e170-6. PubMed ID: 23744810 [TBL] [Abstract][Full Text] [Related]
4. Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation. Teperman LW; Poordad F; Bzowej N; Martin P; Pungpapong S; Schiano T; Flaherty J; Dinh P; Rossi S; Subramanian GM; Spivey J Liver Transpl; 2013 Jun; 19(6):594-601. PubMed ID: 23447407 [TBL] [Abstract][Full Text] [Related]
5. Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation. Singer GA; Zielsdorf S; Fleetwood VA; Alvey N; Cohen E; Eswaran S; Shah N; Chan EY; Hertl M; Fayek SA Transplant Proc; 2015 Mar; 47(2):478-84. PubMed ID: 25769595 [TBL] [Abstract][Full Text] [Related]
6. Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy. Wong SN; Chu CJ; Wai CT; Howell T; Moore C; Fontana RJ; Lok AS Liver Transpl; 2007 Mar; 13(3):374-81. PubMed ID: 17318855 [TBL] [Abstract][Full Text] [Related]
7. Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation. Khemichian S; Hsieh MJ; Zhang SR; Limurti J; Kim J; Fong TL Dig Dis Sci; 2015 Sep; 60(9):2807-12. PubMed ID: 25939541 [TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of tenofovir in the prevention of hepatitis B virus recurrence following liver transplantation. Hakim GD; Akarsu M; Karademir S; Unek T; Astarcıoğlu İ Turk J Gastroenterol; 2014 Dec; 25(6):685-9. PubMed ID: 25599782 [TBL] [Abstract][Full Text] [Related]
9. Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients. Fernández I; Loinaz C; Hernández O; Abradelo M; Manrique A; Calvo J; Manzano M; García A; Cambra F; Castellano G; Jiménez C Transpl Infect Dis; 2015 Oct; 17(5):695-701. PubMed ID: 26257166 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation. Cholongitas E; Vasiliadis T; Antoniadis N; Goulis I; Papanikolaou V; Akriviadis E Transpl Infect Dis; 2012 Oct; 14(5):479-87. PubMed ID: 22624695 [TBL] [Abstract][Full Text] [Related]
11. Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation. Cholongitas E; Goulis I; Antoniadis N; Fouzas I; Imvrios G; Giakoustidis D; Giouleme O; Papanikolaou V; Akriviadis E; Vasiliadis T Transpl Infect Dis; 2016 Oct; 18(5):667-673. PubMed ID: 27421122 [TBL] [Abstract][Full Text] [Related]
12. Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only. Karlas T; Hartmann J; Weimann A; Maier M; Bartels M; Jonas S; Mössner J; Berg T; Tillmann HL; Wiegand J Transpl Infect Dis; 2011 Jun; 13(3):299-302. PubMed ID: 21159112 [TBL] [Abstract][Full Text] [Related]
14. The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence. Idilman R; Akyildiz M; Keskin O; Gungor G; Yilmaz TU; Kalkan C; Dayangac M; Cinar K; Balci D; Hazinedaroglu S; Tokat Y Clin Transplant; 2016 Oct; 30(10):1216-1221. PubMed ID: 27409074 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort. Alvarez-Uria G; Ratcliffe L; Vilar J HIV Med; 2009 May; 10(5):269-73. PubMed ID: 19210695 [TBL] [Abstract][Full Text] [Related]
16. A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis. Angus PW; Patterson SJ; Strasser SI; McCaughan GW; Gane E Hepatology; 2008 Nov; 48(5):1460-6. PubMed ID: 18925641 [TBL] [Abstract][Full Text] [Related]
17. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061 [TBL] [Abstract][Full Text] [Related]
18. Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade. Neff GW; O'brien CB; Nery J; Shire N; Montalbano M; Ruiz P; Nery C; Safdar K; De Medina M; Tzakis AG; Schiff ER; Madariaga J Liver Transpl; 2004 Nov; 10(11):1372-8. PubMed ID: 15497163 [TBL] [Abstract][Full Text] [Related]
19. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation]. Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352 [TBL] [Abstract][Full Text] [Related]
20. Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis. Wadhawan M; Gupta S; Goyal N; Taneja S; Kumar A Liver Transpl; 2013 Sep; 19(9):1030-5. PubMed ID: 23788470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]